Matches in SemOpenAlex for { <https://semopenalex.org/work/W2124669074> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2124669074 endingPage "191" @default.
- W2124669074 startingPage "190" @default.
- W2124669074 abstract "Colorectal cancer (CRC) is the second leading cause of cancer-related mortality and the fourth most common malignant neoplasm in the USA. Depending on the stage at diagnosis, liver and lung metastases occur in about 20–70% and 10–20% of patients, respectively. Unfortunately, distant metastases are the major cause of death for patients with advanced CRC. Despite use of standard therapies for metastatic CRC, treatment has only minimally improved survival, resulting in a medium survival of ∼2 years. As current chemotherapeutic drugs are used at maximum tolerated doses or high dose in standard therapies, toxicity remains a major issue for patients. Therefore, if the standard therapies could have prolonged breaks between successive cycles of drug administration, this could allow for recovery from toxic side effects. To solve this problem, Dr. Timothy Browder at Harvard Medical School first proposed metronomic chemotherapy to minimise toxicity by targeting the tumour-associated endothelium via frequent use of chemotherapeutic drugs at low doses over a longer period of time. Although the definition of metronomic chemotherapy varies, it now generally refers to the continuous administration of traditional chemotherapy, sometimes on a daily basis, at relatively low, minimally toxic doses, for longer periods. This emerging approach has been extensively evaluated in clinical trials and animal models.1 Hackl et al 2 report for the first time that metronomic oral topotecan therapy in adjuvant and metastatic settings prolongs survival and reduces liver metastasis in mouse models of metastatic CRC. Their findings provide a rational for clinical trials of metronomic oral topotecan …" @default.
- W2124669074 created "2016-06-24" @default.
- W2124669074 creator A5010952997 @default.
- W2124669074 creator A5014835615 @default.
- W2124669074 creator A5090373031 @default.
- W2124669074 date "2012-06-08" @default.
- W2124669074 modified "2023-09-26" @default.
- W2124669074 title "Metronomic topotecan for colorectal cancer: a promising new option" @default.
- W2124669074 cites W1977356115 @default.
- W2124669074 cites W2002920284 @default.
- W2124669074 cites W2039725154 @default.
- W2124669074 cites W2086946381 @default.
- W2124669074 cites W2088452019 @default.
- W2124669074 cites W2090806526 @default.
- W2124669074 cites W2101928585 @default.
- W2124669074 cites W2121113526 @default.
- W2124669074 cites W2125857654 @default.
- W2124669074 cites W2159342260 @default.
- W2124669074 cites W2169580709 @default.
- W2124669074 doi "https://doi.org/10.1136/gutjnl-2012-302410" @default.
- W2124669074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22684481" @default.
- W2124669074 hasPublicationYear "2012" @default.
- W2124669074 type Work @default.
- W2124669074 sameAs 2124669074 @default.
- W2124669074 citedByCount "9" @default.
- W2124669074 countsByYear W21246690742013 @default.
- W2124669074 countsByYear W21246690742014 @default.
- W2124669074 countsByYear W21246690742016 @default.
- W2124669074 countsByYear W21246690742017 @default.
- W2124669074 countsByYear W21246690742018 @default.
- W2124669074 countsByYear W21246690742019 @default.
- W2124669074 countsByYear W21246690742021 @default.
- W2124669074 countsByYear W21246690742023 @default.
- W2124669074 crossrefType "journal-article" @default.
- W2124669074 hasAuthorship W2124669074A5010952997 @default.
- W2124669074 hasAuthorship W2124669074A5014835615 @default.
- W2124669074 hasAuthorship W2124669074A5090373031 @default.
- W2124669074 hasConcept C121608353 @default.
- W2124669074 hasConcept C126322002 @default.
- W2124669074 hasConcept C143998085 @default.
- W2124669074 hasConcept C2776694085 @default.
- W2124669074 hasConcept C2781209748 @default.
- W2124669074 hasConcept C526805850 @default.
- W2124669074 hasConcept C60644358 @default.
- W2124669074 hasConcept C71924100 @default.
- W2124669074 hasConcept C86803240 @default.
- W2124669074 hasConceptScore W2124669074C121608353 @default.
- W2124669074 hasConceptScore W2124669074C126322002 @default.
- W2124669074 hasConceptScore W2124669074C143998085 @default.
- W2124669074 hasConceptScore W2124669074C2776694085 @default.
- W2124669074 hasConceptScore W2124669074C2781209748 @default.
- W2124669074 hasConceptScore W2124669074C526805850 @default.
- W2124669074 hasConceptScore W2124669074C60644358 @default.
- W2124669074 hasConceptScore W2124669074C71924100 @default.
- W2124669074 hasConceptScore W2124669074C86803240 @default.
- W2124669074 hasIssue "2" @default.
- W2124669074 hasLocation W21246690741 @default.
- W2124669074 hasLocation W21246690742 @default.
- W2124669074 hasOpenAccess W2124669074 @default.
- W2124669074 hasPrimaryLocation W21246690741 @default.
- W2124669074 hasRelatedWork W2033445808 @default.
- W2124669074 hasRelatedWork W2059153951 @default.
- W2124669074 hasRelatedWork W2061018452 @default.
- W2124669074 hasRelatedWork W2117976189 @default.
- W2124669074 hasRelatedWork W2124273755 @default.
- W2124669074 hasRelatedWork W2392730113 @default.
- W2124669074 hasRelatedWork W2412406379 @default.
- W2124669074 hasRelatedWork W2466209479 @default.
- W2124669074 hasRelatedWork W3004259476 @default.
- W2124669074 hasRelatedWork W4244238644 @default.
- W2124669074 hasVolume "62" @default.
- W2124669074 isParatext "false" @default.
- W2124669074 isRetracted "false" @default.
- W2124669074 magId "2124669074" @default.
- W2124669074 workType "article" @default.